Future technologies include a proprietary coating technology which facilitates extracting performance and clinical data directly from XPF padding. Applications currently under development with working prototypes include:

Our patent pending process converts standard conventional open cell polyurethane foam to an auxetic state. Our process is chemical free and operates at ambient temperatures, severely limiting material property variations, both within a lot and between lots. We can adjust our process to create auxetic foam ranging from a Poisson’s ration of 0.00 to -0.50.